Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment incentives.
FDA approves Chinese eye cancer treatment for development support in the US
RELATED ARTICLES
Sputnik Reporters, Wounded by Ukraine’s Forces, Receive Medical Care in Donetsk
Italian Prime Minister Meloni meets with Trump at his Florida resort
Russia Demands UNESCO’s Reaction to Ukraine’s Attack on Journalists in DPR
